Bristol-Myers Squibb Company stock is trading -19.6% below its average target price of $62.82 after dropping -1.1% during today's evening session. Analysts are giving the large-cap Pharmaceutical company an average rating of hold and target prices ranging from $50.0 to $90.0 per share.
The stock has a very low short interest at 1.3%, and a short ratio of 1.83. At 0.09%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation. Finally, we also note that an average number of institutional investors are invested in the stock, with 79.6% of Bristol-Myers Squibb Company's shares being owned by this investor type.
Institutions Invested in Bristol-Myers Squibb Company
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-09-30 | Vanguard Group Inc | 10% | 199,743,249 | $10,089,031,171 |
| 2023-09-30 | Blackrock Inc. | 8% | 170,659,316 | $8,620,001,764 |
| 2023-09-30 | JP Morgan Chase & Company | 5% | 96,740,383 | $4,886,356,582 |
| 2023-09-30 | State Street Corporation | 4% | 89,474,244 | $4,519,343,914 |
| 2023-09-30 | Capital International Investors | 3% | 69,419,930 | $3,506,400,547 |
| 2023-09-30 | FMR, LLC | 2% | 43,020,893 | $2,172,985,233 |
| 2023-09-30 | Geode Capital Management, LLC | 2% | 39,703,047 | $2,005,400,837 |
| 2023-09-30 | Morgan Stanley | 2% | 36,621,957 | $1,849,774,986 |
| 2023-09-30 | Bank of America Corporation | 1% | 28,165,925 | $1,422,660,824 |
| 2022-12-31 | Norges Bank Investment Management | 1% | 26,041,644 | $1,315,363,394 |
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Bristol-Myers Squibb Company.
